RET (GLP-1 + GIP + Glucagon) 5 mg

Description

RET is a modern peptide being investigated as a breakthrough agent for the treatment of obesity and type 2 diabetes. It acts as an agonist of three hormones (GIP, GLP-1, and glucagon), regulating glucose levels and body fat. In clinical studies, it demonstrated significant weight reduction (an average of 17.5% in 24 weeks) and improved blood sugar control.

RET supports weight loss by reducing appetite and increasing metabolic rate, while also positively influencing cardiovascular health and lipid profiles.

Laboratory reagent – for research purposes only
This product is classified as a chemical reagent intended exclusively for research purposes and should be handled by qualified professionals in laboratory conditions. It is not a dietary supplement, medication, or food product and is not intended for human consumption. All product information is provided for educational purposes only.